Provided are methods for treating inflammatory diseases in a patient comprising administering to the patient an effective amount of a conjugate consisting essentially of one or more antibody fragments covalently attached to one or more nonproteinaceous polymer molecules, wherein at least one antibody fragment comprises an antigen binding site that binds to human IL-8, and wherein the apparent size of the conjugate is at least about 500 kD.

 
Web www.patentalert.com

< (none)

< Controlled release dosage form of [R-(Z)]-.alpha.-(methoxyimino)-.alpha.-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride

> Blank for a decorator's tool

> (none)

~ 00049